Recent research progress in structural optimization and cancer treatment of novel selective FGFR inhibitors (2020-2025).
1/5 보강
Abnormalities in protein tyrosine kinases (PTKs) are one of the primary drivers of cancer.
APA
Liu R, Qi J, et al. (2026). Recent research progress in structural optimization and cancer treatment of novel selective FGFR inhibitors (2020-2025).. International immunopharmacology, 172, 116249. https://doi.org/10.1016/j.intimp.2026.116249
MLA
Liu R, et al.. "Recent research progress in structural optimization and cancer treatment of novel selective FGFR inhibitors (2020-2025).." International immunopharmacology, vol. 172, 2026, pp. 116249.
PMID
41576567 ↗
Abstract 한글 요약
Abnormalities in protein tyrosine kinases (PTKs) are one of the primary drivers of cancer. As a receptor subfamily, fibroblast growth factor receptors (FGFRs) comprise four subtypes-FGFR1 to FGFR4. Their abnormal intracellular expression is a significant cause of tumorigenesis, making FGFRs key therapeutic targets in cancer treatment. This paper primarily summarizes the latest research advances in FGFR inhibitors, aiming to provide insights for future design and synthesis studies of FGFR inhibitors.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Editorial: Advancing NSCLC treatment: overcoming challenges in immune checkpoint inhibitor therapy.
- Mechanistic insights into the roles of astragalosides and polysaccharides in gynecological and breast cancers (Review).
- Predicting cervical lymph node metastasis in papillary thyroid carcinoma using capsule disruption length measured by 3D-US.
- Ginkgolic acid targets HSPA8 to trigger ferroptosis in hepatocellular carcinoma chaperone-mediated autophagy-dependent GPX4 degradation.
- Investigation of a Sc-radiolabelled PDGFRβ-targeted affibody in SPECT imaging and radiotherapy for pancreatic cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.